La Jolla Pharmaceutical Stock

La Jolla Pharmaceutical Dividend 2024

La Jolla Pharmaceutical Dividend

0 USD

La Jolla Pharmaceutical Dividend yield

Ticker

LJPC

ISIN

US5034596040

WKN

A1XB6B

How much dividend does La Jolla Pharmaceutical 2024 pay?

According to the latest status from October 2024, La Jolla Pharmaceutical paid a total of 0 USD per share in dividends within the last 12 months. With the current La Jolla Pharmaceutical price of 6.22 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical La Jolla Pharmaceutical Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the La Jolla Pharmaceutical Dividend Safe?

La Jolla Pharmaceutical has been increasing the dividend for 0 years.

Over the past 10 years, La Jolla Pharmaceutical has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding La Jolla Pharmaceutical's Dividend Distributions

La Jolla Pharmaceutical’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining La Jolla Pharmaceutical's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

La Jolla Pharmaceutical's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in La Jolla Pharmaceutical’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

La Jolla Pharmaceutical Aktienanalyse

What does La Jolla Pharmaceutical do?

La Jolla Pharmaceutical Co is a biopharmaceutical company specializing in the development and marketing of medicines for the treatment of rare and severe diseases. It was founded in 1989 in San Diego, California, by physician and scientist Ivor Royston. The company's business model is focused on researching, developing, and marketing drugs for patients with rare or severe diseases. The company prioritizes the needs and requirements of patients and aims to tailor each medication to maximize effectiveness. La Jolla's main focus is on researching medications for severe and rare diseases such as sepsis, acute kidney failure, and lung inflammation. These medications are intended to help patients who have limited or no treatment options. The company's portfolio includes various drugs, with antibodies being an important component for the treatment of inflammation and autoimmune diseases. Notably, Giapreza is one of the company's well-known medications approved by the FDA in December 2017, designed to treat adult patients with severe or most severe septic shock by increasing blood pressure. LJPC-401 is another significant medication developed by La Jolla Pharmaceutical Co, intended for the treatment of lupus nephritis, an autoimmune-related kidney inflammation that affects about 50% of systemic lupus erythematosus (SLE) patients. The company is also working on the development of a medication for migraine treatment, aiming to reduce the severity and frequency of migraine attacks. Overall, La Jolla Pharmaceutical Co has made significant progress in expanding its research activities and is committed to developing innovative medications to improve the lives of patients with rare and severe diseases. The company's focus on patient needs has proven to be a strategic advantage, positioning it competitively for the future. La Jolla Pharmaceutical is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The La Jolla Pharmaceutical stock can be added to a savings plan with the following providers: Trade Republic

Frequently Asked Questions about La Jolla Pharmaceutical stock

How much dividend does La Jolla Pharmaceutical pay?

Over the past 12 months, La Jolla Pharmaceutical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, La Jolla Pharmaceutical is expected to pay a dividend of 0 USD.

What is the dividend yield of La Jolla Pharmaceutical?

The current dividend yield of La Jolla Pharmaceutical is .

When does La Jolla Pharmaceutical pay dividends?

La Jolla Pharmaceutical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of La Jolla Pharmaceutical?

La Jolla Pharmaceutical paid dividends every year for the past 0 years.

What is the dividend of La Jolla Pharmaceutical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is La Jolla Pharmaceutical located?

La Jolla Pharmaceutical is assigned to the 'Health' sector.

Wann musste ich die Aktien von La Jolla Pharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of La Jolla Pharmaceutical from 10/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/24/2024.

When did La Jolla Pharmaceutical pay the last dividend?

The last dividend was paid out on 10/24/2024.

What was the dividend of La Jolla Pharmaceutical in the year 2023?

In the year 2023, La Jolla Pharmaceutical distributed 0 USD as dividends.

In which currency does La Jolla Pharmaceutical pay out the dividend?

The dividends of La Jolla Pharmaceutical are distributed in USD.

Andere Kennzahlen von La Jolla Pharmaceutical

Our stock analysis for La Jolla Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of La Jolla Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.